期刊文献+

脑肿瘤干细胞放射敏感性的实验研究 被引量:2

Experimental research of radiosensitivity for brain tumor stem cell
下载PDF
导出
摘要 目的评价脑肿瘤干细胞(brain tumorstem cell,BTSC)与胶质瘤细胞系SHG-44细胞放射敏感性的差异。方法SHG-44细胞分别接种于含10%胎牛血清的DMEM/F12培养基和无血清的DMEM/F12培养基(添加bFGF和EGF)中。CD133免疫细胞化学染色鉴定BTSC。0、0.5、1、2、3、4、6、8、10、20GyX线照射SHG-44细胞和BTSC后以流式细胞仪检测两种细胞的细胞周期及细胞凋亡率,绘制SHG-44细胞和BTSC的存活曲线。结果SHG-44细胞中存在BTSC,后者能在无血清的DMEM/F12培养基中存活并悬浮生长,增殖形成克隆球,具有自我更新和增殖能力,表达特异性标志物CD133。两种细胞在X线照射后细胞周期无明显差异,BTSC的细胞凋亡率低于SHG-44细胞(P<0.05),细胞存活率高于SHG-44细胞(P<0.01)。结论BTSC的放射敏感性较SHG-44细胞明显降低,是胶质瘤放疗抵抗的主要原因。 Objective To evaluate difference of radiosensitivity for brain tumor stem cell(BTSC) and human glioma cell line SHG-44 cell.Methods SHG-44 was cultured in DMEM/F12 supplemented with 10% FBS,and in serum-free DMEM/F12 containing bFGF and EGF respectively.BTSC was detected by immunocytochemistrical staining with antibodies against CD133.BTSC and SHG-44 cell were irradiated by X-rays with doses of 0,0.5,1,2,3,4,6,8,10,20 Gy respectively,and flow cytometry assay was used to detecte the apoptosis and analyze the changes of cell cycles.Cell survival curves of BTSC and SHG-44 cell were determined by the measure of cell clone formation.Results SHG-44 cell contained BTSC,which could survive and grow by means of suspension in serum-free medium and proliferate into the clonal sphere.The clonal spheres maintained strong ability of self-renewal and proliferation.The specific marker CD133 could be expressed by BTSC.After BTSC and SHG-44 cell were irradiated by X-rays,flow cytometry assay showed that no different could be found in cell cycles and the ratios of apoptosis in BTSC were lower than that of SHG-44 cell significantly(P〈0.05).The cell survival curves assay showed that the ratios of cell clone formation in BTSC was higher than that of SHG-44 cell(P〈0.01).Conclusions Radiosensitivity of BTSC is lower than that of SHG-44 cell,and it is main cause of glioma radioresistence.
作者 柯金 何杰
出处 《现代医学》 2009年第3期192-195,共4页 Modern Medical Journal
关键词 脑肿瘤干细胞 SHG-44细胞 胶质瘤 放射敏感性 brain tumor stem cell SHG-44 cell glioma radiosensitivity
  • 相关文献

参考文献11

  • 1Stupp R, Mason W P, van den Bent M J, et al. Radiotherapy plus con-comitant and adjuvant temozolomide for glioblastoma [ J]. N Engl J Med,2005,352(10) :987-996.
  • 2Marx J. Cancer research. Mutant stem cells may seed cancer [ J ]. Science, 2003,301 ( 5638 ) : 1308-1310.
  • 3Singh S K, Clarke I D, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors[ J]. Cancer Res,2003, 63(18) :5821-5828.
  • 4Hemmati H D, Nakano I, Lazareff J A, et al. Cancerous stem cells can aries from pediatric brain tumors [ J ]. Proc Natl Acad Sci USA ,2003,100(12) : 15178-15183.
  • 5Singh S K, Hawkins C, Clark I D, et al. Identification of human brain tumor initiating cells [ J ]. Nature, 2004,432 ( 7015 ) : 396-401.
  • 6Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma [ J ]. Cancer Res ,200d, 64 ( 19 ) :7011-7021.
  • 7殷蔚伯,谷铣之.临床放射治疗学[M].3版.北京:中国协和医科大学出版社,2002:426-427.
  • 8Bao S, Wu Q, McLendon R E, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response[ J]. Nature ,2006,444 (7120) :756-760.
  • 9Curman D, Cinel B, Williams D E, et al. Inhibition of the G2 DNA damage checkpoint and of protein kinases Chkl and Chk2 by the marine sponge alkaloid debromohymenialdisine[ J]. J Biol Chem,2001,276(21 ) :17914-17919.
  • 10Shiloh Y. The ATM-mediated DNA-damage response: taking shape [ J ]. Trends Biochem Sci, 2006,31 ( 7 ) : 402 - 410.

同被引文献82

  • 1李珠明,崔玉琴.三维适形放疗与立体定向放射外科治疗脑胶质瘤初步临床分析[J].现代肿瘤医学,2006,14(1):12-13. 被引量:4
  • 2周陈华,马胜林.脑胶质瘤的放射治疗进展[J].肿瘤研究与临床,2006,18(4):280-282. 被引量:14
  • 3赵中甫,杨波,关方霞,宋来君,杨永,樊锐太,张智峰,孙剑瑞,胡祥.脑胶质瘤不同位点肿瘤干细胞的特性分析[J].郑州大学学报(医学版),2007,42(2):365-366. 被引量:4
  • 4姬西团,章翔,费舟,张剑宁,刘卫平,蒋晓帆,宋少军,宋蕾,梁景文.人胚胎神经干细胞体外条件下对胶质瘤细胞的趋向性特点[J].中国组织工程研究与临床康复,2007,11(24):4690-4692. 被引量:1
  • 5Reya T,Morrison S J,Clarke M F. Stem cel s,cancer stem cel s[J].{H}NATURE,2001,(6859):105-111.
  • 6Singh SK,Clarke ID,Terasaki M. Identification of a cancer stem cel in human brain tumors[J].{H}CANCER RESEARCH,2003,(18):5821-5828.
  • 7Cheshier SH,Kalani MY,Lim M. A neurosurgeon's guide to stem cel s,cancer stem cel s,and brain tumor stem cel s[J].{H}NEUROSURGERY,2009,(02):237-250.
  • 8Cheng JX,Liu BL,Zhang X. How powerful is CD133 as a cancer stem cel marker in brain tumors[J].{H}Cancer Treatment Reviews,2009,(05):403-408.
  • 9Pirtoli L,Rubino G,Marsili S. Three-dimensional conformal radiotherapy,temozolomide chemotherapy,and high-dose fracdonated stereotactic boost in a protocol-driven,postoperative treatment schedule for high-grade gliomas[J].{H}TUMORI,2009.329-337.
  • 10Louis DN,Ohgaki H,Wiestler OD. The 2007 WHO classification of tumours of the central nervous system[J].{H}Acta Neuropathologica,2007,(02):97-109.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部